Citation: Hg. Preuss et Jf. Burris, ADVERSE METABOLIC EFFECTS OF ANTIHYPERTENSIVE DRUGS - IMPLICATIONS FOR TREATMENT, Drug safety, 14(6), 1996, pp. 355-364
Authors:
MCGEE TJ
FERRARE RA
WHITEMAN DN
BUTLER JJ
BURRIS JF
OWENS MA
Citation: Tj. Mcgee et al., LIDAR MEASUREMENTS OF STRATOSPHERIC OZONE DURING THE STOIC CAMPAIGN, JOURNAL OF GEOPHYSICAL RESEARCH-ATMOSPHERES, 100(D5), 1995, pp. 9255-9262
Citation: Jf. Burris, THE EXPANDING ROLE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN THEMANAGEMENT OF HYPERTENSION, Journal of clinical pharmacology, 35(4), 1995, pp. 337-342
Authors:
FRISHMAN WH
BURRIS JF
MROCZEK WJ
WEIR MR
ALEMAYEHU D
SIMON JS
CHEN SY
BRYZINSKI BS
Citation: Wh. Frishman et al., FIRST-LINE THERAPY OPTION WITH LOW-DOSE BISOPROLOL FUMARATE AND LOW-DOSE HYDROCHLOROTHIAZIDE IN PATIENTS WITH STAGE-I AND STAGE-II SYSTEMICHYPERTENSION, Journal of clinical pharmacology, 35(2), 1995, pp. 182-188
Citation: Jf. Burris, BEYOND CONTROLLING BLOOD-PRESSURE IN THE BLACK PATIENT - METABOLIC CONSIDERATIONS, Journal of the National Medical Association, 87(5), 1995, pp. 359-362
Authors:
RAM CVS
AMES RP
APPLEGATE WB
BURRIS JF
DAVIDOV ME
MROCZEK WJ
Citation: Cvs. Ram et al., DOUBLE-BLIND COMPARISON OF AMLODIPINE AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Clinical cardiology, 17(5), 1994, pp. 251-256
Citation: Jf. Burris et al., THE EFFECT OF AMLODIPINE ON AMBULATORY BLOOD-PRESSURE IN HYPERTENSIVEPATIENTS, The American journal of cardiology, 73(3), 1994, pp. 10000039-10000043
Citation: Jf. Burris, BETA-BLOCKERS, DYSLIPIDEMIA, AND CORONARY-ARTERY DISEASE - A REASSESSMENT, Archives of internal medicine, 153(18), 1993, pp. 2085-2092